Cite
HARVARD Citation
Simões, J. et al. (n.d.). 382PDSecond-line treatment of bevacizumab plus lomustine versus bevacizumab plus irinotecan in patients with recurrent glioblastoma. Annals of oncology. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Simões, J. et al. (n.d.). 382PDSecond-line treatment of bevacizumab plus lomustine versus bevacizumab plus irinotecan in patients with recurrent glioblastoma. Annals of oncology. p. . [Online].